NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
2 | 2D 1H-13C HSQC | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
3 | 2D 1H-13C CT-HSQC | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
4 | 3D CBCA(CO)NH | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
5 | 3D HNCO | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
6 | 3D HNCA | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
7 | 3D C(CO)NH TOCSY | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
8 | 3D HBHA(CO)NH | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
9 | 3D H(CCO)NH TOCSY | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
10 | 3D H(C)CH-TOCSY aliphatic | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
11 | 3D (H)CCH-TOCSY aliphatic | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
12 | 3D 15N-NOESY-HSQC | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
13 | 3D 13C-NOESY-HSQC aliphatic | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
14 | 3D 13C-NOESY-HSQC aromatic | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
15 | 3D H(C)CH-TOCSY aromatic | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
16 | 2D 1H-15N HSQC long range | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
17 | 2D HBCBCGCDHD | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |
18 | 2D HBCBCGCDCEHE | 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8 | 90% H2O/10% D2O | 0.300 | 7.0 | ambient | 298 | |